Jubilant Organosys Ltd., an integrated Pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India today announced that it had acquired Speciality Molecules Pvt. Ltd., a niche manufacturer of Speciality Intermediates with manufacturing facilities located in Ambarnath (near Mumbai) in India. The purchase consideration to acquire 100% stake is Rs. 199.5 million on a debt free, cash free basis.

The acquired company is engaged in the business of developing, manufacturing and selling of speciality intermediates, which include primarily pyridine derivatives that are used in pharmaceuticals and other life science industry. The acquisition will be accretive to Jubilant’s earnings from the date of acquisition and will strengthen Jubilant’s ability to provide comprehensive offering of pyridine derivatives to the customers in life science industry.

Commenting on the development, Mr. Shyam S Bhartia, Chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director of Jubilant Organosys said: “The acquisition of Speciality Molecules is yet another step in strengthening our global leadership position in pyridine derivatives. This acquisition willstr further engthen Jubilant’s Halogenation capabilities as we plan to sell and also use these speciality intermediates captively for various life science derivateives which will help us to offer products based on a common platform at very competitive prices to our global customers who are sector leaders in the pharma and agrochemicals business”. 

Sourced From: Jubilant Organosys Ltd